Christopher M. Counter

Conference Cancer Research · April 14, 2023 AbstractPancreatic ductal adenocarcinoma (PDAC) is almost uniformly lethal. It is thus imperative to find new therapeutic approaches to treat this disease. While whole genome CRISPR/Cas9 screens have success ... Full text Cite

Altering RAS oncogenic activity defines unique oncogenic fates.

Conference CANCER RESEARCH · July 2021 Link to item Cite

Abstract IA14: Rare codons capacitate Kras-driven de novo tumorigenesis

Conference Cancer Research · March 15, 2017 AbstractThe KRAS gene is commonly mutated in human cancers, rendering the encoded small GTPase constitutively active and oncogenic. We discovered that this gene has the unusual feature of having a bias towar ... Full text Cite

TELOMERES AND TELOMERASE - BIOCHEMISTRY AND REGULATION IN SENESCENCE AND IMMORTALIZATION

Conference CHROMOSOME · January 1, 1993 Link to item Cite